The de-identification of healthcare data permits research innovation while not sacrificing patient privacy, HealthITSecurity reports, noting, “both the healthcare and pharmaceutical industries are beginning to adopt this approach.” Eli Lily Office of Medical Transparency Director Ben Rotz notes, “As we have a set of rules that are followed, as we start to see standards in place for how the data are collected, then we're going to start to see more and more technologies emerge that allow for a standard way to anonymize the data," adding, "As more and more of that tends to happen, people can concentrate on the why and the what of what they're doing instead of the how do they make it happen from a technology perspective.” Note: Joseph Jerome, CIPP/US, wrote a recent Privacy Tech post about de-identification as “a critical part of every privacy pro’s toolbox.”
Full Story